Aisling Capital Management LP - TALARIS THERAPEUTICS INC ownership

TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 49 filers reported holding TALARIS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Aisling Capital Management LP ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$460,000
-85.1%
175,000
-74.4%
0.30%
-86.1%
Q2 2022$3,080,000
-54.2%
682,9230.0%2.20%
-39.4%
Q1 2022$6,720,000
-35.6%
682,9230.0%3.63%
-1.6%
Q4 2021$10,442,000
+12.8%
682,9230.0%3.68%
+99.5%
Q3 2021$9,260,000
-7.7%
682,9230.0%1.85%
+15.0%
Q2 2021$10,032,000682,9231.61%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,932,606$5,513,2996.67%
BML Capital Management, LLC 1,929,484$3,627,4303.14%
Western Standard LLC 586,481$1,102,5841.12%
Cormorant Asset Management, LP 900,649$1,6930.11%
Artal Group S.A. 914,262$1,7190.10%
Values First Advisors, Inc. 52,896$99,4450.06%
Blackstone Inc. 8,089,315$15,207,9120.06%
Eventide Asset Management 1,561,092$2,934,8530.05%
Marquette Asset Management, LLC 101,375$190,5850.05%
VIKING GLOBAL INVESTORS LP 3,289,617$6,184,4800.03%
View complete list of TALARIS THERAPEUTICS INC shareholders